An international field study for the reliability and validity of the EORTC Communication Questionnaire EORTC QLQ-COMU26

Author:

Arraras Juan Ignacio1,Giesinger Johannes2,Shamieh Omar3,Bahar Iqbal4,Koller Michael5,Bredart Anne6,Costantini Anna7,Greimel Eva8,Sztankay Monika2,Wintner Lisa M.2,de Sousa Marina Carreiro9,Ishiki Hiroto10,Kontogianni Meropi11,Wolan Maja12,Kikawa Yuichiro13,Lanceley Anne14,Gioulbasanis Ioannis15,Harle Amelie16,Zarandona Uxue1,Kulis Dagmara17,Kuljanic Karin18

Affiliation:

1. Hospital Universitario de Navarra, Navarra Institute for Health Research (IdiSNA)

2. Medical University of Innsbruck

3. King Hussein Cancer Center

4. Cachar Cancer hospital and Research Centre

5. University Hospital Regensburg

6. Institut Curie and City University

7. Sant'Andrea Universitary Hospital

8. Medical University Graz

9. University dos Acores

10. National Cancer Center Hospital

11. Harokopio University

12. University of Rzeszow

13. Kobe City Medical Center General Hospital

14. University College London

15. Animus Kyanus Stavros General Clinic

16. University Hospitals Dorset

17. European Organisation for Research and Treatment of Cancer

18. University Hospital Center Rijeka

Abstract

Abstract

Background The EORTC Quality of Life Group has developed a questionnaire to evaluate cancer patients’ perception of their communication with healthcare professionals (HCPs): the EORTC QLQ-COMU26. In this study we test the validity and reliability of this novel measure in an international and culturally diverse sample of cancer patients. Methods Cancer patients completed the following EORTC questionnaires at two time points (before and during treatment): the QLQ-COMU26 (including a debriefing questionnaire), the QLQ-C30, and specific IN-PATSAT32 scales. These data were used to assess: the cross-cultural applicability, acceptability, scale structure, reliability, convergent/divergent validity, known-groups validity, and responsiveness to change of the QLQ-COMU26. Results Data were collected from 498 patients with various cancer diagnoses in 10 European countries, Japan, Jordan and India (overall 5 cultural regions). At most, only 3% patients identified an item as confusing and 0.6% as upsetting, indicating that the questionnaire was well understood and accepted. Confirmatory factor analysis and multi-trait scaling confirmed the hypothesised QLQ-COMU26 scale structure comprising six multi-item scales and four single items (RMSEA = 0.025). Reliability was good for all scales (internal consistency > 0.70; test–retest reliability > 0.85). Convergent validity was supported by correlations of ≥ 0.50 with related scales of the IN-PATSAT32 and correlations < 0.30 with unrelated QLQ-C30 scales. Known-groups validity was shown according to sex, age, education, levels of anxiety and depression, satisfaction with communication, disease stage and treatment intention, professional evaluated, and having a companion during the visit. The QLQ-COMU26 captured changes over time in groups that were defined based on changes in the item of satisfaction with communication. Conclusion The EORTC QLQ-COMU26 is a reliable and valid measure of patients’ perceptions of their communication with HCPs. The EORTC QLQ-COMU26 can be used in daily clinical practice and research and in various cancer patient groups from different cultures. This questionnaire can help to improve communication between patients and healthcare professionals.

Publisher

Research Square Platform LLC

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3